NCT02376920View on ClinicalTrials.gov

5 Year Registry Study to Track Clinical Application of DecisionDx-UM Assay Results and Associated Patient Outcomes

CompletedOBSERVATIONAL
Enrollment

93

Participants

Timeline

Start Date

March 31, 2010

Primary Completion Date

April 30, 2022

Study Completion Date

April 30, 2022

Conditions
Uveal Melanoma
Sponsors
All Listed Sponsors
lead

Castle Biosciences Incorporated

INDUSTRY